Abstract
The simplified epithelium of the human prostate gland is representative of a slowly growing but morphologically dynamic tissue. The normal prostate gland contains, in part, the persistent basal cell population and the putative stem cells. It has been postulated by others that the transformation of normal glandular structures into cancer glands and subsequent tumor progression may involve aberrant regulation of the stem cell population. In this chapter, the induction of cytokeratin 6 expression is postulated to participate in the transition of a stem cell from its specialized niche within the basal cell population into a differentiated state. The basic morphological features of the normal prostate gland are reviewed and the molecular features of the prostate stem cells are discussed. Data is presented to illustrate the defining features of a new epithelial phenotype in the prostate gland, containing both cytokeratin 6 expression and the capability to differentiate and reach from the basal cell layer to the luminal surface of the gland. These results underscore the plasticity of the epithelial cell layers and the potential for cytokeratin 6 to serve as an efficient marker for an important subset of the basal cell population. Further investigation will be required in animal models to determine the essential nature of the cytokeratin 6 expression for the normal development of the prostate gland.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
REFERENCES
American Cancer Society: Cancer Facts and Figures. Atlanta, GA. American Cancer Society, 2004.
Ekman, P. Genetic and environmental factors in prostate cancer genesis: identifying high-risk cohorts. Eur Urol. 35(5–6): 362–9, 1999.
Gardner, W. Hypothesis: the prenatal origins of prostate cancer. Human Pathology 26: 1291–1292, 1995.
Gardner, W., Culberson, D. Atrophy and proliferation in the young adult prostate. J Urol. 137: 53–56, 1987.
Isaacs, J., Coffey, D. Etiology and disease process of benign prostatic hyperplasia. The Prostate 2: 33–50, 1989.
Reya, T., Morrison S., Clarke, M., Weissman, I. Stem cells, cancer and cancer stem cells. Nature 414: 105–111, 2001.
di, Sant'Agnese, P., Cockett, A. Neuroendocrine differentiation in prostatic malignancy.Cancer 78: 357–361, 1996.
Liu, A, True, L., LaTray, L., Nelson, P., Ellis, W., Vessella, R., Lange, P., Hood, L., Van den, Engh, G. Cell-cell interaction in prostate gene regulation and cytodifferentiation. Proc Nat Acad Sci, USA 94: 10705–10710, 1997.
McDonnell, T., Troncoso, P., Brisbay, S., Logothetis, C., Chung, L., Hsieh, J., Tu, S., Campbell, M. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52: 6940–6944, 1992.
Bonkhoff, H., Stein, U., Remberger, K. Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate. Hum Pathol. 25: 42–46, 1994.
Sherwood, E., Berg, L., Mitchell, N., McNeal, J., Kozlowski, J., Lee, C. Differential cytokeratin expression in normal hyperplastic and malignant epithelial cells from human prostate. J Urol. 143: 167–171, 1990.
Nagle, R., Hao, J., Knox, J., Dalkin, B., Clark, V., Cress, A. Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am J Pathol. 146: 1498–507, 1995.
Brar, P.K., Dalkin, B.L., Weyer, C., Sallam, K., Virtanen, I., Nagle, RB. Laminin alpha-1, alpha-3, and alpha-5 chain expression in human prepubetal benign prostate glands and adult benign and malignant prostate glands. The Prostate, 55 (1): 65–70, 2003.
Bissell, M., Nelson, W. Cell-to-cell contact and extracellular matrix. Integration of form and function: the central role of adhesion molecules. Curr Opin Cell Biol. 11: 537, 1999.
Green, K., Jones, J. Desmosomes and hemidesmosomes: Structure and function of molecular components. FASEB J. 10: 871–880, 1996.
Olumi, A.F., Grossfeld, G.D., Hayward, S.W., Carroll, P.R., Tlsty, T.D., Cunha, G.R. Carcinoma-associated Fibroblasts Direct Tumor Progression of Initiated Human Prostatic Epithelium. Cancer Res. 59: 5002–5011, 1999.
Sakr, W.A., Haas, G.P., Cassin, B.J., Pontes, J.E., Crissman, J.D. Frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J. Urol 150: 379–385; 1993.
Sakr, W.A., Grignon, D.J., Crissman, J.D., Heilbrun, L.K., Cassin, B.J., Pontes, J.J., Haas, G.P. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69. An autopsy study of 249 cases. In Vivo 8: 439–443; 1994.
Qian, J., Wollan, P., Bostwick, D.G. The extent and multicentricity of high grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum Pathol 28 (2): 143–148, 1997.
Bostwick, D.G. Target populations and strategies for chemoprevention trials of prostate cancer. J Cell Biochem Suppl.19: 191–6, 1994.
Sakr, W.A., Grigon, D.J., Haas, G.P., Schomer, K.L., Heilbrun, L.K., Cassin, B.J., Powerll, I.J., Montie, J.A., Pontes, J.E., Crissman, J.D. Epidemiology of high grade prostatic intraepithelial neoplasia. Pathol Res Pract 19 (9): 838–41, 1995.
Bostwick, D.G., Qian, J., Frankel, K. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol. 154 (5): 1791–4, 1995.
DeMarzo, A.M., Nelson, W.G., Isaacs, W.B., Epstein, J.I. Pathological and molecular aspects of prostate cancer. Lancet 361(9361): 955–64, 2003.
Montironi, R., Galluzzi, C.M., Diamanti, L., Giannulus, I., Pisani, E., Scarpelli, M. Prostatic intra-epithelial neoplasia: expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei. Virchows Arch A Pathol Anat Histopathol. 422(3): 185–92, 1993.
Isaacs, J.T. Molecular markers of prostate cancer metastasis. Am J Pathol 150: 1511, 1997.
Lara, P.N. Jr., Kung, H.J., Gumerlock, P.H., Meyers, F.J. Molecular biology of prostate carcinogenesis. Crit Rev Oncol Hematol. 32 (3): 197–208, 1999.
Ruijter, E., Montironi, R., van de Kaa, C., Schalken, J. Molecular changes associated with prostate cancer development. Anal Quant Cytol Histol 23 (1): 67–88, 2001.
Cress, A.E., Rabinovitz, I., Zhu, W., Nagle, R.B. The α6β1 and α6β4 integrins in human prostate cancer progression. Cancer Metastasis Rev 14: 219–228, 1995.
Schmelz, M., Cress, A.E., Scott, K.M., Bürger, F., Cui, H., Sallam, K., McDaniel, K.M., Dalkin, B.L., Nagle, R.B. Different Phenotypes in Human Prostate Cancer : α6 or α3 Integrin in Cell-Extracellular Adhesion Sites. Neoplasia 4 (3), 2002.
Bonkhoff, H., Remberger, K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. The Prostate 28: 98–106, 1996.
Bussemakers, M., van Bokhoven, A., Tomita, K., Jansen, C.F., Schalken, J.A. Complex cadherin expression in human prostate cancer cells. Int J Cancer 85: 446–450, 2000.
Zha, S., Ferdinandusse, S., Denis, S., Wanders, R.J., Ewing, C.M., Luo, J., De Marzo A.M., Isaacs, WB. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res: 63 (21): 7365–76, 2003.
Rhodes, D.R., Sanda, M.G., Otte, A.P., Chinnaiyan, A.M, Rubin, M.A. Multiplex biomarker approach for determining risk of prostate specific antigen defined recurrence of prostate cancer. J Natl Cancer Inst. 95: 66–81, 2003.
Cheng, L., Song, S.Y., Pretlow, T.G., Abdul-Karim, F.W., Rung, H.J., Dawson, D.V., Park, WS, Moon, Y.W., Tsai, M.L., Linehan, W.M., Emmert-Buck, M.R., Liotta, L.A., Zhuang, Z. Evidence of independent origin of multiple tumors from patients with prostate cancer. J Natl. Cancer Inst. 90: 233–7, 1998.
Wheeler, T.M., Rogers, E., Aihara, M., Scardino, P.T., Thompson, T.C. Apoptotic index as a biomarker in prostatic intraepithelial neoplasia (PIN) and prostate cancer. J Cell Biochem 19: 202–7, 1994.
Verhagen, A.P., Ramaekers, F.C., Aalders, T.W., Schaafsma, H.E., Debruyne, F.M., Schalken, J.A. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 52: 6182, 1992.
Djakiew, D. Dysregulated expression of growth factors and their receptors in the development of prostate cancer. The Prostate 42: 150–160, 2000.
Bui, M., Reiter, R. Stem cell genes in androgen-independent prostate cancer. Cancer and Metastasis Reviews 17: 391–399, 1999.
Hayward, S., Baskin, L., Haughney, P., Cunha, A., Foster, B., Dahiya, R., Prins, G., Cunha, GR. Epithelial development in the rat ventral prostate, anterior prostate and seminal vesicle. Acta Anat (Basel) 155: 81–93, 1996.
English, H., Santen, R., Isaacs, J. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. The Prostate 11: 229–42, 1987.
Ferguson, J., Zincke, H., Ellison, E., Bergstrahl, E., Bostwick, D.G. Decrease of prostatic intraepithelial neoplasia (PIN) following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy. Urol 44: 91–95, 1994.
Trapman, J., Brinkman, A.O. The androgen receptor in prostate cancer. Patho Res Prect 192: 752–60, 1996.
Nelson, W.G., De Marzo, A.M., Isaacs, W.B. Prostate cancer. New Engl. J Med. 349: 366, 2003.
Gronberg, H. Prostate cancer epidemiology. Lancet 361: 859, 2003.
Potten, C., Loeffier, M. Stem cells: attritubes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110: 1001–20, 1990.
Paradis, V., Dargere, D., Laurendeau, I., Benoit, G., Vidaud, M., Jardin, A., Bedossa, P. Expression of the RNA component of human telomerase (htr) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue. J Pathol. 189: 213–218, 1999.
Walensky, L., Coffey, D., Chen, T., Wu, T., Pasternack, G. A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal. Cancer Res. 53: 4720–6, 1993.
Reiter, R., Gu, Z., Watabe, T., Thomas, G., Szigeti, K., Davis, E., Wahl, M., Nisitani, S., Yamashiro, J., Le Beau, M., Loda, M., Witte, O. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA. 95: 1735, 1998.
De Marzo, A., Nelson, W., Meeker, A., Coffey, D. Stem cell features of benign and malignant prostate epithelial cells. J Urol. 160: 2381–2392, 1998.
Moskaluk, C., Duray, P., Cowan, K., Linehan, M., Merino, M. Immunohistochemical expression of pi-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate. Cancer 79: 1595, 1997.
Sherr, C. Cancer cell cycles. Science 274: 1675, 1996.
De Marzo, A., Meeker, A., Epstein, J., Coffey, D. Prostate stem cell compartments: expression of p27Kipl in normal, hyperplastic and cancer cells. American Journal of Pathology 153: 911–918, 1998.
Hudson, D.L., Guy, A.T., Fry, P., O'Hare, M.J., Watt, F.M., Master, JRW. Epithelial Cell Differentiation Pathways in the Human Prostate: Identification of Intermediate Phenotypes by Keratin Expression. J. Histochem. Cytochem. 49: 271–278, 2001.
Collins, A., Habib, F., Maitland, N., Neal, D. Identification and isolation of human prostate epithelial stem cells based on α2β1-integrin expression. Journal of Cell Science 114: 3865–3872, 2001.
Hudson, D., O'Hare, M., Watt, F., Masters, J. Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. Laboratory Investigations 80: 1243–1250, 2000.
Richardson, G.D., Robson, C.N., Lang, S.H., Neal, D.E., Maitland, N.J., Collins, A.T. CD 133, a novel marker for human prostatic stem cells. J Cell Sci 117: 3539–3545, 2003.
Burger, P.E., Xiong, X., Coetzee, S., Salm, S.N., Moscatelli, D., Goto, K., Wilson, E.L. Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. PNAS, 102 (20): 7180–7185, 2005.
Xia, T., Blackburn, W., Gardner, W. Fetal prostate growth and development. Pediatr Pathol. 10: 527–537, 1990.
Sugimura, Y., Sakurai, M., Hayashi, N., Yamashita, A., Kawamura, J. Age-related changes of the prostate gland in the senescence-accelerated mouse. The Prostate 24: 24–32, 1994.
Gardner, W., Bennett, B. The prostate-overview: recent insights and speculations. In Gardner, W.A., Weinstein, R.S. (eds): Pathology and Pathobiology of Urinary Bladder and Prostate. Baltimore, Williams & Wilkins. 129–148, 1992.
Pylkkanen, L., Makela, S., Valve, E., Harkonen, P., Toikkanen, S., Santti, R. Prostatic dysplasia associated with increased expression of C-MYC in neonatally estrogenized mice. J. Urol. 149: 1593–601, 1993.
Prins, G. Developmental estrogenization of the prostate gland. In: Prostate: Basic and Clinical Aspects. (Ed. R.K. Naz, CRC Press: Boca Raton, FL). 247–65, 1997.
Cunha, G., Donjacour, A., Cooke, P., Mee, S., Bigsby, R., Higgins, SJ., Sugimura, Y. The endocrinology and developmental biology of the prostate. Endocrine Reviews 8: 338–362, 1987.
Thomson, A. Role of androgens and fibroblast growth factors in prostatic development. Reproduction 121: 187–195, 2001.
Lowsley, O. The development of the human prostate gland with reference to the development of other structures at the neck of the urinary bladder. Am J Anat. 13: 299, 1912.
Kellokumpu-Lethinen, P., Santti, R., Pelliniemi, L. Correlation of early cyto-differentiation of the human fetal prostate and Leydig cells. Anat. Rec. 196: 263, 1980.
Wang, Y., Hayward, S., Cao, M., Thayer, K., Cunha, GR. Cell differentiation lineage in the prostate. Differentiation 68: 270–279, 2001.
Hayward, S., Baskin, L., Haughney, P., Foster, B., Cunha, A., Dahiya, R., Prins, G., Cunha, G.R. Epithelial development in the rat ventral prostate, anterior prostate and seminal vesicle. Acta Anat (Basel)155: 81–93, 1996.
Donjacour, A., Cunha, G.R. Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice. Endocrinology 131: 2342–2350, 1993.
Podlasek, C., Clemens, J., Bushman, W. Hoxa-13 gene mutation results in abnormal seminal vesicle and prostate development. J. Urol. 161: 1655–1661, 1999.
Oefelein, M., Chin-Chance, C., Bushman, W. Expression of the homeotic gene Hox-dl3 in the developing and adult mouse prostate. J. Urol. 155: 342–346, 1996.
Bhatia-Gaur, R., Donjacour, A.A, Sciavolino, P.J., Kim, M., Desai, N., Young, Norton C.R., Gridley, T., Cardiff, R.D., Cunha, G.R., Abate-Shen, C., Shen, M.M. Roles for Nkx3.1 in prostatedevelopment and cancer. Genes Dev. 13: 966–977, 1999. Acta Anat (Basel) 155: 94–103,1996.
Sugimura, Y., Foster, B., Horn, Y., Lipschutz, J., Rubin, J., Finch, P., Aaronson, S., Hayashi, N. Kawamura, J., Cunha, G.R. Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int. J. Dev. Biol. 40: 941–951, 1996.
Thomson, A., Cunha, G.R. Prostatic growth and development are regulated by FGF10. Development 126: 3693–3701, 1999.
Ruan, W., Powell-Braxton, L., Kopchick, J., Kleinberg, D. Evidence that insulin-like growth factor 1 and growth hormone are required for prostate gland development. Endocrinology 140: 1984–1989, 1999.
Salm, S.N., Burger, P., Coetzee, S., Goto, K., Moscatelli, D., Wilson, E.L. TGF-β maintains dormancy of prostatic stem cells in the proximal region of ducts.
Wang, B.-E., Shou, J., Ross, S., Koeppen, H., de Sauvage, F.J., Gao, W.-Q. Inhibition of Epithelial Ductal Branching in the Prostate by Sonic Hedgehog Is Indirectly Mediated by Stromal Cells. J. Biol. Chem. 278: 18506–18513, 2003.
Lamm, M., Catbagan, W., Laciak, R., Barnett, D., Hebner, C., Gaffield, W., Walterhouse, D., Iannaccone, P. Sonic hedgehog activates mesenchymal Glil expression during prostate ductal bud formation. Developmental Biol. 249: 349–366, 2002.
Marker, P., Stephan, J.P., Lee, J., Bald, Mather J., Cunha, G.R. Fucosyltransferase 1 and H-Type complex carbohydrates modulate epithelial cell proliferation during prostatic branching morphogenesis. Dev. Biol. 233: 95–108, 2001.
Ide, H., Seligson, D., Memarzadeh, S., Xin, L., Horvath, S., Dubey, P., Flick, M., Kacinski, B., Palotie, A., Witte, O. Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression. PNAS 99: 14404–14409, 2002.
Signoretti, S., Waltregny, D., Dilks, J., Isaac, B., Lin, D., Garraway, L., Yang, A., Montironi, R., McKeon, F., Loda, M. p63 Is a Prostate Basal Cell Marker and Is Required for Prostate. Development. Am J Pathol. 157: 1769–1775, 2000.
Gakunga, P., Frost, G., Shuster, S., Cunha, G., Formby, B., Stern, R. Hyaluronan is a prerequisit for ductal branching morphogenesis. Development 124: 3987–3997, 1997.
Elfman, F., Bok, R., Conn, M., Shuman, M., Cunha, G.R. Urokinase plasminogen activator amino-terminal peptides inhibit development of the rat ventral prostate. Differentiation 69: 108–120, 2001.
Lamm, M., Podlasek, C., Barnett, D., Lee, J., Clemens, J., Hebner, C., Bushman, W. Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate. Developmental Biol. 232: 301–314, 2001.
Cancilla, B., Jarred, R., Wang, H., Mellor, S., Cunha, G., Risbridger, G. Regulation of prostate branching morphogenesis by activin A and follistatin. Dev. Biol. 237: 145–158, 2001.
Schmelz, M., Moll, R., Hesse, U., Prasad, A.R., Gandolfi, J.A., Hasan, S.R., Bartholdi, M., Cress, A.E. Identification of a stem cell candidate in the normal human prostate gland. Eur J Cell Biol 84: 341–354.
McGowan, K., Coulombe, P. The wound repair-associated keratins 6, 16 and 17. Insights into the role of intermediate filaments in specifying keratinocyte cytoarchitecture. Subcellular Biochemistry: Intermediate Filaments, eds. Herrmann and Harris. 31: 173–204, 1998.
Parrish, A., Sallam, K., Nyman, D., Orozco, J., Cress, A.E., Dalkin, B., Nagle, R., Gandolfi, A. Culturing precision-cut human prostate slices as an in vitro model of prostate pathobiology. Cell Biol Toxicol 18: 205–219, 2002.
Smalley, M., Ashworth, A. Stem cells and breast cancer: a field in transit. Nat Rev Cancer 3: 832–844, 2003.
Stasiak, P., Purkis, P., Leigh, I., Lane, E. Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol 92: 707–716, 1989.
Hudson, D.L., Guy, A., Fry, P., O'Hare, M.J., Watt, F.M., Masters, J.R.W. Epithelial Cel Differentiation pathways in the human prostate : Identification of intermediate phenotypes by keratin expression. J Histochem Cytochem 49: 271–278, 2001.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer
About this chapter
Cite this chapter
Schmelz, M., Prasad, A. (2006). CYTOKERATIN 6 EXPRESSION IN PROSTATE STEM CELLS. In: Cress, A.E., Nagle, R.B. (eds) Cell Adhesion and Cytoskeletal Molecules in Metastasis. Cancer Metastasis – Biology and Treatment, vol 9. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-5129-6_6
Download citation
DOI: https://doi.org/10.1007/978-1-4020-5129-6_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-5128-9
Online ISBN: 978-1-4020-5129-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)